Dynamic Technology Lab Private Ltd Raises Stake in Cabot Co. (NYSE:CBT)

Dynamic Technology Lab Private Ltd raised its holdings in shares of Cabot Co. (NYSE:CBT - Free Report) by 153.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,870 shares of the specialty chemicals company's stock after acquiring an additional 14,449 shares during the period. Cabot makes up about 0.4% of Dynamic Technology Lab Private Ltd's portfolio, making the stock its 24th biggest position. Dynamic Technology Lab Private Ltd's holdings in Cabot were worth $2,179,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CBT. R Squared Ltd purchased a new position in Cabot during the fourth quarter valued at approximately $26,000. EverSource Wealth Advisors LLC grew its stake in shares of Cabot by 37.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock worth $74,000 after purchasing an additional 219 shares during the period. GAMMA Investing LLC increased its holdings in shares of Cabot by 10.7% during the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after purchasing an additional 130 shares in the last quarter. Manchester Capital Management LLC lifted its stake in shares of Cabot by 1,685.1% in the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock valued at $153,000 after purchasing an additional 1,584 shares during the period. Finally, Coldstream Capital Management Inc. acquired a new stake in Cabot during the third quarter valued at $226,000. Institutional investors and hedge funds own 93.18% of the company's stock.

Cabot Price Performance

CBT stock traded down $4.03 during trading on Thursday, hitting $76.86. The stock had a trading volume of 155,829 shares, compared to its average volume of 384,827. The company's 50-day moving average price is $83.85 and its two-hundred day moving average price is $96.35. Cabot Co. has a twelve month low of $73.63 and a twelve month high of $117.46. The stock has a market capitalization of $4.17 billion, a P/E ratio of 10.18, a PEG ratio of 0.74 and a beta of 1.04. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. As a group, research analysts predict that Cabot Co. will post 7.57 EPS for the current fiscal year.

Cabot Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were given a dividend of $0.43 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.72 dividend on an annualized basis and a yield of 2.24%. Cabot's payout ratio is presently 22.84%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on CBT shares. Mizuho decreased their price objective on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a research report on Tuesday, January 7th. JPMorgan Chase & Co. reduced their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a report on Friday, February 21st. StockNews.com lowered Cabot from a "buy" rating to a "hold" rating in a report on Wednesday. Finally, UBS Group reduced their target price on Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research note on Monday. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $93.25.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.